Quanterix, Novartis forge SiMoA technology evaluation deal
Quanterix CEO David Okrongly said they are excited to initiate this technology evaluation with Novartis, one of the world’s leading healthcare companies. "Through this collaborative project, we hope
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.